A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)

Clinical trial NCT07455045 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07455045
Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

High Grade Glioma (III or IV)Diffuse Midline Glioma (DMG)Glioblastoma (GBM)

Start date: 2026-03-01
Primary completion: 2027-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.